STAAR Surgical Company SR3.F Stock
STAAR Surgical Company Price Chart
STAAR Surgical Company SR3.F Financial and Trading Overview
STAAR Surgical Company stock price | 47.98 EUR |
Previous Close | 46.6 EUR |
Open | 47.79 EUR |
Bid | 47.82 EUR x 34300 |
Ask | 48.42 EUR x 33000 |
Day's Range | 47.79 - 47.79 EUR |
52 Week Range | 43.77 - 108.25 EUR |
Volume | 50 EUR |
Avg. Volume | 2 EUR |
Market Cap | 2.31B EUR |
Beta (5Y Monthly) | 1.179577 |
PE Ratio (TTM) | 79.65 |
EPS (TTM) | 0.4 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 147 EUR |
SR3.F Valuation Measures
Enterprise Value | 2.16B EUR |
Trailing P/E | 79.65 |
Forward P/E | 62.064938 |
PEG Ratio (5 yr expected) | 10.93 |
Price/Sales (ttm) | 7.837444 |
Price/Book (mrq) | 6.8144875 |
Enterprise Value/Revenue | 7.322 |
Enterprise Value/EBITDA | 54.814 |
Trading Information
STAAR Surgical Company Stock Price History
Beta (5Y Monthly) | 1.179577 |
52-Week Change | -18.28% |
S&P500 52-Week Change | 20.43% |
52 Week High | 108.25 EUR |
52 Week Low | 43.77 EUR |
50-Day Moving Average | 58.02 EUR |
200-Day Moving Average | 63.83 EUR |
SR3.F Share Statistics
Avg. Volume (3 month) | 2 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 48.33M |
Float | 39.2M |
Short Ratio | N/A |
% Held by Insiders | 0.72% |
% Held by Institutions | 101.89% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 30, 2023 |
Profitability
Profit Margin | 10.81% |
Operating Margin (ttm) | 11.77% |
Gross Margin | 78.61% |
EBITDA Margin | 13.35% |
Management Effectiveness
Return on Assets (ttm) | 5.63% |
Return on Equity (ttm) | 10.35% |
Income Statement
Revenue (ttm) | 294.72M EUR |
Revenue Per Share (ttm) | 6.13 EUR |
Quarterly Revenue Growth (yoy) | 16.30% |
Gross Profit (ttm) | 223.38M EUR |
EBITDA | 39.37M EUR |
Net Income Avi to Common (ttm) | 31.86M EUR |
Diluted EPS (ttm) | 0.6 |
Quarterly Earnings Growth (yoy) | -71.79% |
Balance Sheet
Total Cash (mrq) | 203.85M EUR |
Total Cash Per Share (mrq) | 4.22 EUR |
Total Debt (mrq) | 31.91M EUR |
Total Debt/Equity (mrq) | 9.41 EUR |
Current Ratio (mrq) | 6.648 |
Book Value Per Share (mrq) | 7.013 |
Cash Flow Statement
Operating Cash Flow (ttm) | 35.23M EUR |
Levered Free Cash Flow (ttm) | 8.17M EUR |
Profile of STAAR Surgical Company
Country | Germany |
State | CA |
City | Lake Forest |
Address | 25651 Atlantic Ocean Drive |
ZIP | 92630 |
Phone | 626 303 7902 |
Website | https://www.staar.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 882 |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Q&A For STAAR Surgical Company Stock
What is a current SR3.F stock price?
STAAR Surgical Company SR3.F stock price today per share is 47.98 EUR.
How to purchase STAAR Surgical Company stock?
You can buy SR3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for STAAR Surgical Company?
The stock symbol or ticker of STAAR Surgical Company is SR3.F.
Which industry does the STAAR Surgical Company company belong to?
The STAAR Surgical Company industry is Medical Instruments & Supplies.
How many shares does STAAR Surgical Company have in circulation?
The max supply of STAAR Surgical Company shares is 48.87M.
What is STAAR Surgical Company Price to Earnings Ratio (PE Ratio)?
STAAR Surgical Company PE Ratio is 119.95000000 now.
What was STAAR Surgical Company earnings per share over the trailing 12 months (TTM)?
STAAR Surgical Company EPS is 0.4 EUR over the trailing 12 months.
Which sector does the STAAR Surgical Company company belong to?
The STAAR Surgical Company sector is Healthcare.